Weight-loss drugs such as Ozempic or Wegovy and Zepbound are being hailed as game-changers in obesity treatment. However, these medications only work to a point; patients quickly lose weight initially, but this slows down and eventually comes to a halt. The pharmaceutical industry looks set to explore further advances in gut hormone-related drugs for weight loss. The aim is to gradually decrease the ‘plateau’ point to achieve greater weight loss. Drugs that stimulate multiple gut hormones could be the key, alongside increased dosages.
100 MILLION Americans in UnitedHealth PII Breach
UnitedHealth confirmed that February’s ransomware attack impacted 100 million people, the largest healthcare data breach in the US. Health insurance, health, billing, and personal information